A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 340 participants.
Also called NCT02916602
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 340 participants
- Registry
-
NCT02916602
-
- Other papers using this trial's data
- Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02916602. Randomized; double masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2016-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605
- Condition
- Hypertension
- Intervention (Drug)
- HCP1401
- Intervention (Drug)
- HCP0605
- Lead sponsor
- Hanmi Pharmaceutical Company Limited
Record details
- Record id
cardio:ct-nct02916602- Content hash
8aeaf5ed062aba1fc7b30f2f9f935fd32074c05d38004959f50941587cc1a973